Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2012 / Article
Special Issue

Biophysical Basis for Meridian and Acupoint Functions

View this Special Issue

Research Article | Open Access

Volume 2012 |Article ID 476457 | https://doi.org/10.1155/2012/476457

Li-Li Cheng, Ming-Xing Ding, Cheng Xiong, Min-Yan Zhou, Zheng-Ying Qiu, Qiong Wang, "Effects of Electroacupuncture of Different Frequencies on the Release Profile of Endogenous Opioid Peptides in the Central Nerve System of Goats", Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 476457, 9 pages, 2012. https://doi.org/10.1155/2012/476457

Effects of Electroacupuncture of Different Frequencies on the Release Profile of Endogenous Opioid Peptides in the Central Nerve System of Goats

Academic Editor: Wolfgang Schwarz
Received25 Jul 2012
Revised11 Sep 2012
Accepted15 Sep 2012
Published24 Oct 2012

Abstract

To investigate the release profile of met-enkephalin, β-endorphin, and dynorphin-A in ruminants’ CNS, goats were stimulated by electroacupuncture of 0, 2, 40, 60, 80, or 100 Hz for 30 min. The pain threshold was measured using potassium iontophoresis. The peptide levels were determined with SABC immunohistochemisty. The results showed that 60 Hz increased pain threshold by 91%; its increasing rate was higher ( ) than any other frequency did. 2 Hz and 100 Hz increased met-enkephalin immunoactivities ( ) in nucleus accumbens, septal area, caudate nucleus, amygdala, paraventricular nucleus of hypothalamus, periaqueductal gray, dorsal raphe nucleus, and locus ceruleus. The two frequencies elicited β-endorphin release ( ) in nucleus accumbens, septal area, supraoptic nucleus, ventromedial nucleus of hypothalamus, periaqueductal gray, dorsal raphe nucleus, locus ceruleus, solitary nucleus and amygdala. 60 Hz increased ( ) met-enkephalin or β-endorphin immunoactivities in the nuclei and areas mentioned above, and habenular nucleus, substantia nigra, parabrachial nucleus, and nucleus raphe magnus. High frequencies increased dynorphin-A release ( ) in spinal cord dorsal horn and most analgesia-related nuclei. It suggested that 60 Hz induced the simultaneous release of the three peptides in extensive analgesia-related nuclei and areas of the CNS, which may be contributive to optimal analgesic effects and species variation.

1. Introduction

Acupuncture is a traditional therapeutic technique in Oriental medicine, which has a long history of 4000 years. As a modern version of hand acupuncture, electroacupuncture (EA) can provide a valid analgesic effect and has little physiological interference [1, 2]. It was successfully used to ameliorate pain not only in varieties of painful diseases [3, 4], but in various operations, such as cesarean section, gastrectomy, enterectomy, and castration, in animals during the 1970s [1, 5]. Since then, analgesia-regulating mechanism of EA has been extensively investigated. Previous studies found that electroacupuncture analgesia (EAA) was involved in modulations of neurotransmitters or neuromodulators in the central nerve system (CNS) [6], and most early studies focused on the role of neurotransmitters such as serotonin, noradrenaline, dopamine, and acetylcholine. Later, it was certified that some endogenous opioid peptides (EOPs), mainly including enkephalin, β-endorphin, and dynorphin, played a more important role in EAA [7, 8]. EA of different frequencies can promote the release of different EOPs in the CNS. Studies showed that EAA induced by 2 Hz (low frequency) was mediated by the release of met-enkephalin (M-ENK) and β-endorphin (β-EP), while EAA by 100 Hz (high frequency) was mediated by the release of dynorphin-A (DYN-A) in the CNS in rats [911]. Although these results in rats above are extrapolated to give reasonable explanations for acupuncture analgesia phenomenon and its treatment of related diseases in human, there are still some unknown mechanisms to be investigated.

It has been proved that analgesia induced by EA varies in animal species. In order to quantitatively estimate the degree of acupuncture-induced analgesia, some researchers used an anesthetic to ensure a complete analgesia and to assess the reduction of the amount of the anesthetics consumed in the EA plus anesthetic group as compared to the anesthetic group without acupuncture. Studies showed that EA in combination with anesthetics resulted in the reduction of the dosage of the anesthetics in human, rat, and goat by 45%–55%, 50%–60%, and over 75%, respectively [12, 13]. It is clear that the analgesic effect induced by EA in goats (ruminants) is superior to that in rats or human. Therefore, the modalities of EOP release elicited by different frequencies in ruminants could be different from those in rats. In the present study, goats were stimulated with EA of different frequencies to determine the analgesic efficacy and the release levels of M-ENK, β-EP, and DYN-A in the CNS in order to probe into the mechanisms of EA-induced analgesia in ruminants.

2. Materials and Methods

2.1. Animal Preparation

Forty-nine healthy 1- to 2-year-old hybrid male goats, weighing 23–28 kg, were purchased from the goat farm of Hubei Agricultural Academy of Science. All experimental goats were randomly divided into seven groups of seven each, maintained on dry grass diet which was supplemented with a cereal-based concentrate, and drank freely. They were dewormed and accustomed to being approached. Feed was withheld for 24 h before the start of the experiment. The experiment was performed in a quiet environment, and the ambient temperature fluctuated between 23°C and 24°C. The experimental protocol was approved by the Animal Care Center, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.

2.2. Electroacupuncture

A set of Baihui (hundred meetings), Santai (three platforms), Ergen (ear base), and Sanyangluo (three Yang communications) points was selected for EA. The anatomic location of these points has been described in detail in veterinary medicine [12, 14]. Needle insertion and EA were conducted with the method reported by Liu et al. [12]. Experimental animals were restrained in right recumbency, and stimulated with EA at 0, 2, 40, 60, 80, or 100 Hz for 30 min via WQ-6F Electronic Acupunctoscope (Beijing Xindonghua Electronic Instrument Co., Ltd., Beijing, China). The goats which were only dealt with needles left in the acupoints without electricity were used as the sham control.

2.3. Determination of Pain Threshold

Just before and after EA, the pain threshold was measured on the center of the left flank using the method of potassium iontophoresis [12, 15, 16]. The region used to measure pain threshold was shaved, cleaned with soap and water, and sterilized with 75% alcohol. Two electrodes soaked with saturated potassium chloride were placed 3 cm apart on the skin in position. A galvanofaradism apparatus (Shantou Medical Equipment Factory Co., Ltd., Shantou, China) was used to deliver pulsed direct current to the electrodes. The voltage was increased stepwise. Obvious contraction of the local skin and muscle was taken as the endpoint; the current was then terminated, and the volt level was recorded. The procedure was repeated three times. The average volt level was obtained. Mean voltages before and after EA were expressed as and , respectively. The change of percentage in pain threshold was calculated as follows: .

2.4. Measurements of the Levels of Endogenous Opioid Peptides

The levels of M-ENK, β-EP, and DYN-A were measured through the method of SABC immunohistochemisty. The nuclei were identified according to the photographic atlas of the goat brain, and the morphological characteristics of the neurons [1719].

Once the pain threshold was measured after EA, the goats were deeply anesthesized with intravenous administration of xylidinothiazoline at 3 mg/kg. Physiological saline was infused through bilateral carotid arteries at the same velocity with which the blood bled out from the jugular veins for about 5 min (until the blood fluid became colorless). Four percent paraformaldehyde instead of the physiological saline was infused for about 1 h. The brain and a part of the adjacent spinal cord were taken out of the skull and cervical vertebral canal. The brain was placed on a paraffin plate with the ventral surface up. Then it was transected into seven sections through the caudal edge of the residual part of the olfactory bulbs, the center of the optic chiasm, the caudal edge of the mamillary body, the sulcus between cerebral peduncles and pons, the sulcus between pons and medulla oblongata, and the caudal borderline between medulla oblongata and spinal cord, respectively. The first section with the residual part of the olfactory bulbs was discarded. The others were put into 4% paraformaldehyde to fix for 48 h. The cerebral cortex and cerebellum were stripped with the amygdala region left. Each of the second to fourth sections was evenly cut into three subsections (S1 to S9), while the fifth and the sixth sections were averagely divided into two and five subsections (S10 to S16), respectively. The seventh section was just spinal cord (S17). The sectionalization of the brain and the localization of nuclei and areas in subsections were illustrated in Figure 1. Each of the subsections was embedded in a paraffin block, sectioned at 5  m, mounted on polylysine-coated slides, deparaffinized, and rehydrated sequentially.

Twelve serial slides were chosen from near the middle of each subsection for immunohistochemical staining. Four of the twelve slides were randomly selected to detect the level of one of EOPs. Of these four slides, the three were incubated with one kind of rabbit-anti-M-ENK IgG (1 : 100), rabbit anti-β-endorphin IgG (1 : 200), or rabbit-anti-DYN-A IgG (1 : 100) (purchased from Wuhan Boster Biological Technology Ltd., Wuhan, China) while the rest was incubated with PBS instead of the corresponding antibody as negative control. Experimental procedures of SABC immunohistochemistry followed the instructions provided by the reagent company (Wuhan Boster Biological Technology Ltd., Wuhan, China). The cytoplasm of positive cells was stained as brown yellow. Optical density of the stained nuclei or area in the CNS was obtained with a light microscope connected to a video-based and computer-linked system (high-resolution pathological image analysis system-1000, Wuhan Qianping Ltd., Wuhan, China). This system was programmed to calculate the mean optical density (MOD) for three fields of each slide examined under 400× magnification. The level of EOPs in each nucleus or area was represented with the mean value ‰  of the mean optical density from the three slides.

2.5. Statistical Analysis

Statistical analysis was performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). All the data presented as . Pain threshold and EOP data were used for ANOVA followed by the Bonferroni’s post hoc test. The correlation coefficient (Pearson’s) was used to examine the relations between pain threshold and EOP level. Statistical significance was evaluated by determining if the value was equal to or less than 0.05.

3. Results

3.1. Effects of EA of Different Frequencies on Pain Threshold

The analgesic effects of EA of different frequencies in goats were expressed as the pain threshold (Figure 2). After EA treatment for 30 min, the pain threshold increased as frequency increased, reached the highest at 60 Hz, but decreased at 80 Hz. Frequencies of 100, 80, 60, 40, and 2 Hz increased pain threshold by 42%, 41%, 91%, 69%, and 35% ( ), respectively. The pain threshold of goats stimulated by 60 Hz was higher ( ) than that by 40 Hz. The pain threshold by either 60 Hz or 40 Hz was higher ( ) than that by 80, 100, or 2 Hz. The pain threshold between goats in sham control and 0 Hz was no difference ( ). Because there was no difference ( ) in pain threshold between goats stimulated with 80 and 100 Hz, the effect of 80 Hz on the release of EOPs was not considered in the following experiment.

3.2. Level of M-ENK Release Induced by Different Frequencies in the CNS

The levels of M-ENK were measured in the analgesia-related nuclei or areas which included nucleus accumbens (ACB), septal area (SA), caudate nucleus (CAU), amygdala (AMY), supraoptic nucleus (SON), paraventricular nucleus of hypothalamus (PVH), ventromedial nucleus of hypothalamus (VMH), periaqueductal gray (PAG), dorsal raphe nucleus (DR), substantia nigra (SN), parabrachial nucleus (PBN), locus ceruleus (LC), nucleus raphe magnus (NRM), and spinal cord dorsal horn (SCD). The release levels of M-ENK between the sham control and 0 Hz were no differences ( ) in the measured nuclei and areas. EA of different frequencies facilitated M-ENK release significantly ( ) in the measured nuclei or areas except NRM, SON and SCD (Table 1). 60 Hz induced M-ENK immunoactivities to increase by over 100% in the measured nuclei and areas except SN, SON, NRM, and SCD, and by over 300% in SA, AMY, and PAG. 100 Hz promoted M-ENK immunoactivities to increase by over 100% in SA, AMY, PVH, VMH, PAG, PBN, and LC, and by over 300% in PBN. 2 Hz increased M-ENK immunoactivities by over 100% in AMY, PVH and PAG. As frequency increased, M-ENK immunoactivities of the forebrain nuclei, and AMY, VMH, and PAG increased, reached the highest at 60 Hz, and then decreased at 100 Hz. There was no difference in M-ENK of VMH, SN or LC between goats stimulated by 60 Hz and 40 Hz, or by 60 Hz and 100 Hz. In DR, M-ENK immunoactivities elicited by 40 or 60 Hz were higher than those by 2 Hz or 100 Hz. There was no difference in M-ENK immunoactivities between goats stimulated by 40 Hz and 60 Hz in this nucleus. In PBN, M-ENK immunoactivities induced by 100 Hz were higher than those by 40 or 2 Hz ( ), but not higher ( ) than those by 60 Hz. In SCD, 2 Hz caused M-ENK immunoactivities to increase ( ) while the frequency of 40, 60 or 100 Hz did not. Statistic analysis showed that the pain thresholds correlated ( ) with M-ENK immunoactivities in the measured nuclei and areas except SON, NRM, and SCD.


Nuclei
and areas
Sham control0 Hz2 Hz40 Hz60 Hz100 HzCorrelation coefficients

ACB 15.60 ± 1.69c15.30 ± 2.97c24.56 ± 2.50b32.69 ± 3.92a35.15 ± 4.41a22.59 ± 2.89b0.888**
SA 14.77 ± 2.39e25.05 ± 1.94d54.95 ± 3.50b60.51 ± 4.35a33.81 ± 3.72c0.923**
CAU 14.35 ± 3.18c22.78 ± 2.92b25.24 ± 5.64b32.66 ± 3.47a26.88 ± 5.48b0.724**
AMY 10.04 ± 2.43d20.49 ± 3.28c35.06 ± 7.69b47.28 ± 5.56a38.45 ± 7.97ab0.795**
SON 32.99 ± 5.0330.54 ± 6.1631.68 ± 8.1731.90 ± 6.4933.73 ± 5.610.071
PVH 17.95 ± 4.25c35.01 ± 6.18b47.38 ± 7.63a46.70 ± 10.22a40.76 ± 3.55ab0.734**
VMH 11.09 ± 3.29b18.47 ± 2.56b36.56 ± 8.99a40.65 ± 10.10a38.19 ± 9.27a0.735**
PAG 7.75 ± 1.16c20.53 ± 3.60b23.29 ± 4.26b33.71 ± 6.73a16.74 ± 2.51b0.808**
DR 0.837**
SN 0.721**
PBN 0.656**
LC 0.799**
NRM 0.263
SCD 0.123

ACB: nucleus accumbens, SA: septal area, CAU: caudate nucleus, AMY: amygdala, SON: supraoptic nucleus, SN: substantia nigra, PAG: periaqueductal gray, NRM: nucleus raphe magnus, PBN: parabrachial nucleus, LC: locus ceruleus, DR: dorsal raphe nucleus, SCD: spinal cord dorsal horn, PVH: paraventricular nucleus of hypothalamus, VMH: ventromedial nucleus of hypothalamus.
Note: There was difference ( ) between the values with different letters, and no difference ( ) with the same letters in a line. *means the levels of the endogenous opioid peptides correlate with the pain thresholds at the 0.05 level, and the levels at the 0.01 level. **The letters and symbols in the following tables have the same meanings as the table above.

3.3. Level of β-EP Release Induced by Different Frequencies in the CNS

The β-EP levels were measured in the analgesia-related nuclei and areas which included ACB, SA, AMY, CAU, SON, arcuate nucleus (ARC), VMH, habenular nucleus (HB), PAG, DR, LC, PBN, NRM, solitary nucleus (SOL), and SCD. There were no differences ( ) in the β-EP immunoactivities between the sham control and 0 Hz in these nuclei and areas. 60 Hz increased β-EP immunoactivities by over 100% in the most measured nuclei and areas, and by over 300% in PAG and SOL, whereas 100 Hz increased β-EP immunoactivities by over 100% in ACB, VMH, PAG, LC, SOL, and AMY. 2 Hz increased β-EP immunoactivities by over 100% in PAG and SOL. Frequencies of 40, 60, and 100 Hz promoted β-EP immunoactivities to decrease ( ) in ARC, but to increase ( ) in the other measured nuclei or areas. The β-EP immunoactivities induced by 2 Hz were higher ( ) than those by 0 Hz in ACB, SA, SON, VMH, PAG, DR, LC, SCD, SOL, and AMY, but not in CAU, ARC, HB, PBN, and NRM. As frequency increased, EA promoted β-EP immunoactivities to change in the measured nuclei and areas except CAU, SON, ARC, HB, PBN, and AMY. In CAU, PBN, and AMY, β-EP immunoactivities induced by either 40 Hz or 60 Hz were higher ( ) than those by 2 Hz or 100 Hz. But no difference existed in β-EP immunoactivities between goats stimulated by 40 Hz and 60 Hz. In SON, there were no differences in β-EP immunoactivities between goats given with 60 Hz and 40 or 100 Hz. The pain thresholds correlated ( ) with β-EP immunoactivities in the measured nuclei and areas (Table 2).


Nuclei
and areas
Sham control0 Hz2 Hz40 Hz60 Hz100 HzCorrelation coefficients

ACB10.57 ± 1.48d9.25 ± 0.44d12.21 ± 2.00c21.01 ± 1.80b27.61 ± 1.91a18.70 ± 1.21b0.891**
CAU20.90 ± 1.99c20.84 ±3.87c24.05 ± 2.99bc36.60 ± 2.17a36.99 ± 2.28a26.81 ± 2.41b0.835**
SA21.04 ± 2.03d20.65 ± 3.58d29.58 ± 2.66c42.08 ± 4.24b49.52 ± 3.02a31.25 ± 3.21c0.893**
AMY18.46 ± 2.45d18.21 ± 3.33d32.95 ± 4.16c53.15 ± 2.74ab54.59 ± 3.09a48.86 ± 3.66b0.840**
SON29.31 ± 1.52c28.88 ± 2.37c38.18 ± 5.30b53.13 ± 2.60a52.68 ± 2.10a51.25 ± 1.87a0.783**
ARC33.45 ± 2.11a33.42 ± 2.34a35.13 ± 2.02a26.83 ± 1.13bc23.76 ± 2.74c28.83 ± 2.63b0.795**
VMH19.81 ± 2.10e18.86 ± 1.79e34.41 ± 2.82d56.30 ± 3.77b61.17 ± 2.35a47.94 ± 1.66c0.897**
HB17.57 ± 2.42c16.12 ± 1.63c18.44 ± 1.49c22.59 ± 2.05b26.37 ± 1.20a27.46 ± 1.30a0.647**
PAG8.40 ± 0.96d8.22 ± 1.23d19.04 ± 1.74c28.82 ± 3.82b33.70 ± 3.36a30.18 ± 3.55ab0.871**
DR18.63 ± 1.83d17.82 ± 2.34d29.07 ± 1.94c34.06 ± 3.09ab38.43 ± 3.45a31.10 ± 3.09bc0.808**
LC14.90 ± 2.21d13.72 ± 2.95d21.01 ± 2.37c30.13 ± 2.66b35.14 ± 2.42a30.35 ± 1.80b0.855**
PBN7.65 ± 1.19b7.54 ± 1.44b8.69 ± 0.99b14.07 ± 2.85a14.92 ± 1.96a7.99 ± 1.15b0.790**
NRM17.37 ± 2.20c16.52 ± 2.23c17.93 ± 1.21c23.50 ± 1.65b30.25 ± 2.91a24.89 ± 1.76b0.779**
SOL11.50 ± 1.02e11.35 ± 0.88e23.41 ± 2.46d33.83 ± 3.64c49.46 ± 1.42a43.59 ± 2.17b0.928**
SCD7.25 ± 1.13d6.80 ± 0.26d10.91 ± 1.00c14.42 ± 1.18b17.72 ± 1.03a10.30 ± 1.26c0.795**

ACB: nucleus accumbens, SA: septal area, CAU: caudate nucleus, AMY: amygdala, SON: supraoptic nucleus, ARC: arcuate nucleus, LC: locus ceruleus, PAG: periaqueductal gray, DR: dorsal raphe nucleus, PBN: parabrachial nucleus, HB: habenular nucleus, NRM: nucleus raphe, SOL: solitary nucleus, VMH: ventromedial nucleus of hypothalamus magnus, SCD: spinal cord dorsal horn.
3.4. Level of DYN-A Release Induced by Different Frequencies in the CNS

The levels of DYN-A were measured in CAU, SA, AMY, SON, PVH, VMH, PAG, PBN, gigantocellular reticular nucleus (GI), and SCD. In these nuclei and areas, DYN-A immunoactivities were no differences ( ) between the sham control and 0 Hz. DYN-A immunoactivities in the CNS increased in a frequency-dependent manner. Frequency of 40, 60, or 100 Hz promoted DYN-A to increase significantly ( ) in the CNS. The DYN-A immunoactivities induced by 100 Hz were different from those by 60 Hz in the measured nuclei and areas except VMH and GI. Statistic analysis showed that the pain thresholds correlated ( ) with DYN-A immunoactivities in the measured nuclei and areas except SCD (Table 3).


Nuclei
and areas
Sham control0 Hz2 Hz40 Hz60 Hz100 HzCorrelation coefficients

CAU9.03 ± 0.57d8.89 ± 0.27d9.77 ± 0.34d17.22 ± 1.05c20.91 ± 1.81b25.37 ± 1.14a0.573**
SA14.93 ± 1.29d14.68 ± 1.11d14.88 ± 0.97d19.82 ± 2.00c26.61 ± 1.30b35.75 ± 1.58a0.400*
AMY10.87 ± 1.10e10.16 ± 0.65e13.03 ± 1.55d17.28 ± 1.40c24.79 ± 1.42b31.34 ± 1.44a0.505**
SON20.73 ± 1.52c20.42 ± 1.08c21.77 ± 1.41c38.35 ± 2.51b38.60 ± 0.94b43.87 ± 1.77a0.652**
PVH8.74 ± 0.83d8.65 ± 0.39d8.85 ± 0.57d17.53 ± 1.39c19.87 ± 1.13b23.24 ± 1.92a0.606**
VMH27.01 ± 1.15c26.36 ± 1.10c27.70 ± 1.22c36.01 ± 1.83b41.10 ± 1.89a42.54 ± 1.49a0.671**
PAG12.27 ± 1.27d12.02 ± 1.28d12.87 ± 1.12d16.94 ± 2.05c19.68 ± 1.90b23.72 ± 1.52a0.457**
PBN9.71 ± 0.74d9.48 ± 0.55d9.31 ± 0.50d16.90 ± 1.73c19.39 ± 1.44b24.44 ± 1.19a0.533**
GI10.53 ± 1.01c10.42 ± 1.32c10.89 ± 1.58c14.27 ± 1.85b19.46 ± 1.60a20.61 ± 1.34a0.555**
SCD3.73 ± 0.26c3.68 ± 0.27c4.06 ± 0.22c5.86 ± 0.19b6.05 ± 0.46b10.27 ± 0.60a0.275

CAU: caudate nucleus, SA: septal area, AMY: amygdala, SON: supraoptic nucleus, PAG: periaqueductal gray, PBN: parabrachial nucleus, GI: gigantocellular reticular nucleus, SCD: spinal cord dorsal horn, PVH: paraventricular nucleus of hypothalamus, VMH: ventromedial nucleus of hypothalamus.

4. Discussion

4.1. The Measurement for Pain Thresholds and the Acupoint Selection for Electroacupuncture

There are a few methods to determine acupuncture-induced change in pain threshold. The tail flick response or paw withdrawal reflex by radiant heat can be used for the measurement of nociceptive threshold in rats [20, 21]. But it is not applicable for larger experimental animals (such as cattle and goats) because of their thick skin and hard hoof structure. The level of analgesia in these animals is commonly determined by scores based on an animal’s response to a pinprick at a particular region [22, 23]. Obviously, this method is influenced by subjective factors. Ludbrook et al. [24] and Grant and Upton [25] measured the pain threshold in goats by using an algesimetry method based on a leg-lifting response to a subcutaneous electric stimulus. This method is not an involuntary reflex but instead a learned cognitive behavior. Additionally, it cannot be used for restrained animals. Potassium iontophoresis is a convenient and reliable experimental pain stimulus that can be presented rapidly and repeatedly with minimal loss in consistency of a subject’s reported pain level [16]. In our study, potassium iontophoresis provided a tool for investigating changes in the pain thresholds of EA-treated goats.

A potent analgesic effect induced by EA depends on proper prescriptions of specific acupoints. “Zusanli” (St.36) and “Sanyinjiao” (SP.6) acupoints are commonly chosen for EA to elevate the pain threshold of the traumatic rats [26, 27]. A few sets of acupoints have been employed for EAA in ruminants. Numerous studies showed that EA at a set of Baihui, Santai, Ergen, and Sanyangluo acupoints elicited an effective analgesia in cattle [5]. Liu et al. [12] demonstrated that EA at this set of acupoints caused a potent analgesic effect in goats. In this study, we adopted this set of acupoints and obtained a similar analgesic effect as Liu did [12]. Experimental investigations showed that stimulation at different acupoints activated different nuclei and areas in rats [2830]. However, whether acupoint specificities would change the releasing modalities of EOPs elicited by EA in the CNS of ruminants deserves to be investigated.

4.2. Distribution of Endogenous Opioid Peptides in the CNS of Goats

EOPs in the CNS include five families: enkephalins, endorphins, dynorphins, endomorphins, and orphanin FQ, of which the roles of M-ENK, β-EP and DYN-A in EA-induced analgesia were best studied. Studies showed that M-ENK was mainly found in CAU, hypothalamus, SON, PVH, VMH, midbrain, formatio reticularis mesencephali, SN, pons, and formatio reticularis medullae oblongatae [31, 32]. β-EP existed in hypothalamus, SON, ARC, parafascicular nucleus, preoptic region, interpeduncular nucleus, olfactory bulb, pons, medulla oblongata, SCD, AMY, cortex, and hippocampus [3335]. DYN-A existed in SOL, medullary lateral reticular structure, preoptic area, periventricular nucleus, SON, ARC, SCD, hypothalamus, midbrain, and forebrain [3638]. In the present study, higher level of β-EP was seen in ARC and SON, as had been reported elsewhere [34]. The rank order of DYN-A levels in our results was VMH > SON > PAG > GI = AMY = PBN = CAU = PVH > SCD, which was similar to reports in human and rats [39, 40]. The highest immunoactivities of M-ENK existed in SON, followed by the lower levels in ACB, CAU, PVH, SA, NRM, and SN, and the lowest levels in PAG, and AMY. These results were some different from the report by Shi et al. [41] that higher level of M-ENK existed in ACB, CAU, SON, PAG and AMY in rats. This discrepancy might be caused by species variation.

4.3. Different Frequencies Induced the Release Profile of EOPs in the CNS of Goats

The veterinary practice proved that frequencies of 40 to 100 Hz are believed to be proper for analgesia of ruminants [5]. But there is a lack of studies to specify this frequency range. In the present study, the increasing magnitude of the pain threshold in goats stimulated by 60 Hz was greater than that by the frequency of 100, 80, 40, or 2 Hz. Obviously, the analgesic effect by 60 Hz was better than that by the others. It is well documented that EOPs exhibit a frequency-dependent response in EA-produced analgesia in rats [4244]. Low frequency (2 Hz) exerts antinociceptive effects mainly by enhancing the release of ENK and β-EP, whereas high frequency (100 Hz) produces antinociceptive effects by facilitating the release of DYN [44]. However, the release profile of goats’ EOPs induced by different frequencies is not clear yet. In this study, 2 Hz and 100 Hz induced M-ENK to increase significantly in ACB, SA, CAU, AMY, PVH, PAG, DR, and LC and caused β-EP to increase significantly in ACB, SA, SON, VMH, PAG, DR, LC, SOL, and AMY. 60 Hz promoted the release of M-ENK or β-EP in the measured nuclei except in ARC. Therefore, 60 Hz activated more nuclei and areas to release M-ENK and β-EP than 2 or 100 Hz did in ruminants. EOPs participate in extensively physiological modulations. Their roles in EA-induced analgesia are verified by microinjecting EOP and its antagonist or antibody into some nuclei in rats. Levels of M-ENK in ACB [45], SA [46], CAU [47], PAG [48], or DR [48], AMY [49], and SN [50, 51] were proved to affect EA-induced analgesic effect. Either were the levels of β-EP in ACB [52], SA [46], CAU [53], PAG [54], DR [55], LC [56], NRM [56], HB [57], or ARC [58]. Our results showed that EA elevated the levels of M-ENK or β-EP in these nuclei of goats. Besides, we also found that M-ENK or β-EP immunoactivities increased in LC, PBN, VMH, SOL, SON, and PVH. It is seen that high frequencies can induce the simultaneous release of M-ENK or β-EP in a broader spectrum of nuclei in ruminants than in rats.

Role of DYN-A in EA-induced analgesia in the brain is controversial. Han and Xie [59] found that DYN-A did not produce EA-induced analgesia when it was microinjected into the cerebral ventricle of rats. Zhang et al. [60] made the opposite conclusion with DYN-A microinjection. In this study, EA induced DYN-A to increase in many analgesia-related nuclei in the CNS. The DYN-A immunoactivities induced by 100 Hz were significantly different from those by 60 Hz in the measured nuclei and areas except VMH and GI. It is shown that VMH and GI in the release of DYN-A were sensitive to both 100 Hz and 60 Hz. Whether the release of DYN-A takes part in EA analgesic modulation in the CNS of ruminants needs to be studied.

Release of DYN-A induced by 100 Hz in the SCD can produce a potent analgesic effect in rats [61]. In this study, EA of high frequencies induced DYN-A to increase in the SCD. This increase was in accordance with that of Han [61]. However, the increase in β-EP immunoactivities of the SCD and its correlation with the pain threshold values were different from the report of some studies in rats [62]. This discrepancy might be caused by the variation of the species or the studied spinal fragment. In this study, SCD samples were taken from the spinal cord adjacent to the medulla oblongata rather than the lumbar spinal cord.

Studies in rats showed that stimulation at 2 Hz and 100 Hz alternatively elicited the full release of M-ENK, β-EP, and DYN-A in the CNS, which produced a synergistic effect stronger than that at 2 Hz or 100 Hz alone [63]. Veterinary practice verifies that the mode of alternating stimulation with low and high frequencies can also induce more potent analgesic effect. However, the releasing modalities of EOPs which are induced by this stimulation mode in ruminants are worthy to be investigated.

4.4. Animal Species Variation of EA-Induced Analgesia

During the last decades, our understanding of how the brain processes acupuncture analgesia has undergone considerable development. But the major results of related researches are primarily obtained from small experimental animals such as rats, rabbits, dogs and monkeys. There are many factors which affect the EA-induced analgesic effect. Besides frequencies and acupoints, species-specificity has an important impact on EA analgesia. Studies showed that EA in combination with anesthetics led to reduce the dosage of the anesthetics in human, rat, and goat by 45%–55%, 50%–60%, and over 75%, respectively [12, 13]. Obviously, ruminants should be optimal model animals for research on the mechanisms of EA-induced analgesia. Our results showed that high frequencies motivated the simultaneous release of the three EOPs in the extensive analgesia-related nuclei and areas in the CNS, which may be conducive to explain why EA induced more potent analgesia in ruminants than in rats.

5. Conclusion

60 Hz was an optimal frequency for acupuncture-induced analgesia in goats and induced the simultaneous release of M-ENK, β-EP, and DYN-A in most of analgesia-related nuclei and areas in the CNS.

Acknowledgments

This study is supported by the funds from the National Natural Science Foundation of China (nos. 30771593 and 31072177) and by the Fundamental Research Funds for the Central Universities of China (no. 2012MBDX009).

References

  1. H. Haltrecht, “Veterinary acupuncture,” Canadian Veterinary Journal, vol. 40, no. 6, pp. 401–403, 1999. View at: Google Scholar
  2. R. Taguchi, “Acupuncture anesthesia and analgesia for clinical acute pain in Japan,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 2, pp. 153–158, 2008. View at: Publisher Site | Google Scholar
  3. X. T. Zhang, Z. P. JI, and J. S. Huang, Acupuncture Studies of Acupuncture Anesthesia, Science Press, 1986.
  4. M. Inoue, H. Kitakoji, T. Yano, N. Ishizaki, M. Itoi, and Y. Katsumi, “Acupuncture treatment for low back pain and lower limb symptoms—the relation between acupuncture or electroacupuncture stimulation and sciatic nerve blood flow,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 2, pp. 133–143, 2008. View at: Publisher Site | Google Scholar
  5. C. L. Chen, Traditional Chinese Veterinary Medicine, Chinese Agriculture Press, 1991.
  6. X. T. Zhang, Z. P. JI, and J. S. Huang, Acupuncture Studies of Acupuncture Anesthesia, Science Press, 1986.
  7. J. S. Han, “Acupuncture and endorphins,” Neuroscience Letters, vol. 361, no. 1–3, pp. 258–261, 2004. View at: Publisher Site | Google Scholar
  8. H. Zhou, H. J. Yu, Y. Wan, Y. Wang, J. K. Chang, and J. S. Han, “Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat,” Neuroscience Letters, vol. 274, no. 2, pp. 75–78, 1999. View at: Publisher Site | Google Scholar
  9. J. S. Han and Q. Wang, “Mobilization of specific neuropeptides by peripheral stimulation of identified frequencies,” News in Physiological Sciences, vol. 7, no. 4, pp. 176–180, 1992. View at: Google Scholar
  10. H. Fei, S. L. Sun, and J. S. Han, “New evidence supporting differential release of enkephalin and dynorphin by low and high frequency electro-acupuncture,” Chinese Science Bulletin, vol. 33, no. 9, pp. 703–705, 1988. View at: Google Scholar
  11. H. Fei, G. X. Xie, and J. S. Han, “Low and high frequency electro-acupuncture stimulations release [met5] enkephalin and dynorphin A in rat spinal cord,” Chinese Science Bulletin, vol. 32, no. 21, pp. 1496–1501, 1987. View at: Google Scholar
  12. D. M. Liu, Z. Y. Zhou, Y. Ding et al., “Physiologic effects of electroacupuncture combined with intramuscular administration of xylazine to provide analgesia in goats,” American Journal of Veterinary Research, vol. 70, no. 11, pp. 1326–1332, 2009. View at: Publisher Site | Google Scholar
  13. J. S. Han, “Acupuncture anesthesia versus Acupuncture-assisted anesthesia,” Acupuncture Research, vol. 22, no. 1, pp. 97–102, 1997. View at: Google Scholar
  14. A. M. Klide and S. H. Kung, Animal Acupuncture Points, Veterinary Acupuncture, University of Pennsylvania, Philadelphia, Pa, USA, 2nd edition, 1982.
  15. G. A. Ulett, S. Han, and J. S. Han, “Electroacupuncture: mechanisms and clinical application,” Biological Psychiatry, vol. 44, no. 2, pp. 129–138, 1998. View at: Publisher Site | Google Scholar
  16. S. A. Humphries, N. R. Long, and M. H. Johnson, “Iontophoretically applied potassium ions as an experimental pain stimulus for investigating pain mechanisms,” Perception and Psychophysics, vol. 56, no. 6, pp. 637–648, 1994. View at: Google Scholar
  17. J. S. Tindal, G. S. Knaggs, and A. Turvey, “The forebrain of the goat in stereotaxic coordinates,” Journal of Anatomy, vol. 103, no. 3, pp. 457–469, 1968. View at: Google Scholar
  18. J. S. Tindal, A. Turvey, and L. A. Blake, “A stereotaxic atlas of the medulla oblongata of the goat's brain,” Journal of Anatomy, vol. 155, pp. 195–202, 1987. View at: Google Scholar
  19. T. Yoshikawa, Atlas of the Brains of Domestic Animals., University of Tokyo Press, Tokyo, Japan, 1967.
  20. M. F. Ren and J. S. Han, “An improved tail-flick test and its application in the study of acupuncture analgesia,” Acta Physiological Sinica, vol. 30, no. 2, pp. 204–208, 1978. View at: Google Scholar
  21. K. Hargreaves, R. Dubner, F. Brown, C. Flores, and J. Joris, “A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia,” Pain, vol. 32, no. 1, pp. 77–88, 1988. View at: Google Scholar
  22. R. DeRossi, E. B. Gaspar, A. L. Junqueira, and M. P. Beretta, “A comparison of two subarachnoid α2-agonists, xylazine and clonidine, with respect to duration of antinociception, and hemodynamic effects in goats,” Small Ruminant Research, vol. 47, no. 2, pp. 103–111, 2003. View at: Publisher Site | Google Scholar
  23. P. Kinjavdekar, G. R. S. Amarpal, H. P. Aithal, and A. M. Pawde, “Physiologic and biochemical effects of subarachnoidally administered xylazine and medetomidine in goats,” Small Ruminant Research, vol. 38, no. 3, pp. 217–228, 2000. View at: Publisher Site | Google Scholar
  24. G. Ludbrook, C. Grant, R. Upton, and C. Penhall, “A method for frequent measurement of sedation and analgesia in sheep using the response to a ramped electrical stimulus,” Journal of Pharmacological and Toxicological Methods, vol. 33, no. 1, pp. 17–22, 1995. View at: Publisher Site | Google Scholar
  25. C. Grant and R. N. Upton, “The anti-nociceptive efficacy of low dose intramuscular xylazine in lambs,” Research in Veterinary Science, vol. 70, no. 1, pp. 47–50, 2001. View at: Publisher Site | Google Scholar
  26. D. Zhang, G. H. Ding, X. Y. Shen et al., “Influence of mast cell function on the analgesic effect of acupuncture of “Zusanli” (ST 36) in rats,” Acupuncture research, vol. 32, no. 3, pp. 147–152, 2007. View at: Google Scholar
  27. V. Senna-Fernandes, D. L. M. França, D. De Souza et al., “Acupuncture at “zusanli” (St.36) and “sanyinjiao” (SP.6) points on the gastrointestinal tract: a study of the bioavailability of 99mTc-sodium pertechnetate in rats,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 823941, 2011. View at: Publisher Site | Google Scholar
  28. S. S. Du, G. L. Du, Y. Q. Wang, M. Liu, Y. Bai, and Z. L. Guan, “Distribution of fos-Li neurons in the spinal trigeminal nucleus after stimulation at acupoints yifeng and fengchi in rats,” " Journal of Shanghai University of Traditional Chinese Medicine, vol. 26, no. 2, pp. 78–82, 2012. View at: Google Scholar
  29. L. P. Yan, L. X. Ji, H. J. Wang et al., “Effects of “weibingfang” stimulated by electroacupuncture on expression of c-fos protein in medulla oblongata and hypothalamus of rats with acute gastric mucosal damage,” Journal of Shanxi College of Traditional Chinese Medicine, vol. 11, no. 5, pp. 9–11, 2010. View at: Google Scholar
  30. M. Qin, Y. X. Huang, J. J. Wang, L. Duan, R. Cao, and Z. R. Rao, “Effects of acupuncture at Tsusanli (He-Sea Point) on expression of FOS and GFAP in medullary visceral zone of rats under stress,” Medical Journal of ChineSe People’S Liberation Army, vol. 30, no. 9, pp. 819–821, 2005. View at: Google Scholar
  31. C. Gramsch, V. Hoellt, and P. Mehraein, “Regional distribution of methione-enkephalin- and beta-endorphin-like immunoreactivity in human brain and pituitary,” Brain Research, vol. 171, no. 2, pp. 261–270, 1979. View at: Publisher Site | Google Scholar
  32. H. Khachaturian, M. E. Lewis, and S. J. Watson, “Enkephalin systems in diencephalon and brainstem of the rat,” Journal of Comparative Neurology, vol. 220, no. 3, pp. 310–320, 1983. View at: Google Scholar
  33. F. Bloom, E. Battenberg, and J. Rossier, “Neurons containing β-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 3, pp. 1591–1595, 1978. View at: Google Scholar
  34. H. Akil, S. J. Watson, and E. Young, “Endogenous opioids: biology and function,” Annual Review of Neuroscience, vol. 7, pp. 223–255, 1984. View at: Google Scholar
  35. A. R. Karuri, S. Ayres, and M. S. A. Kumar, “Regional distribution of gonadotropin-releasing hormone-like, β-endorphin-like, and methionine-enkephalin-like immunoreactivities in the central nervous system of the goat,” Brain Research Bulletin, vol. 51, no. 1, pp. 63–68, 2000. View at: Publisher Site | Google Scholar
  36. E. Weber and J. D. Barchas, “Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and α-neo-endorphin systems,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 4, pp. 1125–1129, 1983. View at: Google Scholar
  37. Z. H. Xiang and G. Q. Gu, “The morphology and distribution of DYN A 1-13 neuron in the rat hypothalamus,” Chinese Journal of Anatomy, vol. 14, no. 4, pp. 304–307, 1991. View at: Google Scholar
  38. J. S. Han and Q. Wang, “Arcuate nucleus (ARH) and parabrachial nucleus (PBN) mediate low-and high-frequency electroacupuncture analgesia,” Acupuncture Research, vol. 8, no. 4, pp. 181–182, 1991. View at: Google Scholar
  39. C. Gramsch, V. Hoellt, and A. Pasi, “Immunoreactive dynorphin in human brain and pituitary,” Brain Research, vol. 233, no. 1, pp. 65–74, 1982. View at: Publisher Site | Google Scholar
  40. V. Höllt, I. Haarmann, K. Bovermann, M. Jerlicz, and A. Herz, “Dynorphin-related immunoreactive peptides in rat brain and pituitary,” Neuroscience Letters, vol. 18, no. 2, pp. 149–153, 1980. View at: Publisher Site | Google Scholar
  41. Y. L. Shi, J. P. Zhang, and W. Z. Bai, “The research progress of enkephalin,” Journal of Hebei Medical University, vol. 28, no. 2, pp. 148–150, 2007. View at: Google Scholar
  42. Z. Q. Zhao, “Neural mechanism underlying acupuncture analgesia,” Progress in Neurobiology, vol. 85, no. 4, pp. 355–375, 2008. View at: Publisher Site | Google Scholar
  43. Z. H. Cho, S. C. Hwang, E. K. Wong et al., “Neural substrates, experimental evidences and functional hypothesis of acupuncture mechanisms,” Acta Neurologica Scandinavica, vol. 113, no. 6, pp. 370–377, 2006. View at: Publisher Site | Google Scholar
  44. J. S. Han, “Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies,” Trends in Neurosciences, vol. 26, no. 1, pp. 17–22, 2003. View at: Publisher Site | Google Scholar
  45. W. Q. Jin, Z. F. Zhou, and J. S. Han, “Inhibition of enkephalins degradation in nucleus accumbens leads to potentiation of acupuncture and morphine analgesia,” Acta Physiologica Sinica, vol. 37, no. 4, pp. 377–382, 1985. View at: Google Scholar
  46. H. Y. Mo, S. P. Ou, and Y. F. Qiu, “Inhibitory effect of septal stimulation on cortical potentials evoked by tooth pulp stimulation in rabbits and its relationship with naloxone and acupuncture analgesia,” Acta Academiae Medicinae Primae Shanghai, vol. 10, no. 6, pp. 463–468, 1983. View at: Google Scholar
  47. C. W. Xie, W. Q. Zhang, X. J. Hong, and J. S. Han, “Relation between the content of central met-enkephalin and leu-enkephalin and the analgesic effect of electroacupuncture in rats,” Acta Physiologica Sinica, vol. 36, no. 2, pp. 192–197, 1984. View at: Google Scholar
  48. J. C. Zhao and D. N. Zhu ", “The further analysis of the acupuncture analgesic role in Dorsal raphe nucleus and its adjacent gray region,” Shaanxi Medical Journal, vol. 9, no. 12, pp. 44–47, 1980. View at: Google Scholar
  49. D. Y. Xu, Z. F. Zhou, and J. S. Han, “Amygdaloid serotonin and endogenous opioid substances (OLS) are important for mediating electroacupuncture analgesia and morphine analgesia in the rabbit,” Acta Physiologica Sinica, vol. 37, no. 2, pp. 162–171, 1985. View at: Google Scholar
  50. A. A. Baumeister, T. G. Anticich, M. F. Hawkins, J. C. Liter, H. F. Thibodeaux, and E. C. Guillory, “Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat,” Brain Research, vol. 447, no. 1, pp. 116–121, 1988. View at: Google Scholar
  51. D. Y. Sun, W. Q. Wang, D. M. Gao, and Z. Q. Lu, “Influences of intranigral injection of kainic acid on electroacupuncture analgesia and morphine analgesia in the rabbits,” Acupuncture research, vol. 11, no. 2, pp. 113–118, 1986. View at: Google Scholar
  52. Q. P. Ma, Y. S. Shi, and J. S. Han, “Periaqueductal gray and nucleus Accumbens influence each other to promote the release of enkephalin and β-endorphin in rabbit brain,” Chinese Science Bulletin, vol. 11, pp. 855–858, 1991. View at: Google Scholar
  53. L. F. He, L. N. Du, X. G. Zhang, Z. Z. Shi, and J. W. Jiang, “Effect of intracaudate microinjection of naloxone on electroacupuncture analgesia,” Acta Academic Medicine Prima Shanghai, vol. 7, no. 5, pp. 332–337, 1980. View at: Google Scholar
  54. G. X. Xie, Z. F. Zhou, and J. S. Han, “Electro-acupuncture analgesia in the rabbit was partially blocked by anti-β-endorphin antiserum injected into periaqueductal grey, but not by its intrathecal injection,” Acupuncture Research, no. 4, pp. 275–280, 1981. View at: Google Scholar
  55. X. Y. Chen, W. P. Yin, and Q. Z. Yin, “The dorsal raphe nucleus is involved in the inhibitory effect of hypothalamic arcuate stimulation on pain-evoked unit discharges of the thalamic parafascicular nucleus,” Acta Physiologica Sinica, vol. 39, no. 1, pp. 46–53, 1987. View at: Google Scholar
  56. Z. D. You, C. Y. Song, C. H. Wang, and B. C. Lin, “Effect of stimulating the supraoptic nucleus and EIectroacupuncture on β-endorphin contents in locus ceruleus and nucleus raphe magnus in rats,” Acupuncture Research, vol. 19, no. 3, pp. 40–41, 1994. View at: Google Scholar
  57. Y. T. Xuan, Z. F. Zhou, W. Y. Wu, and J. S. Han, “Antagonism of acupuncture analgesia and morphine analgesia by microinjection of cinanserin into nucleus accumbens or habenula in the rabbit,” Journal of Beijing Medical College, vol. 14, no. 1, pp. 23–26, 1982. View at: Google Scholar
  58. Q. L. Chen, H. C. Liu, F. Gu, and Q. Z. Yin, “Effects of neonatal administration of monosodium glutamate on acupuncture analgesia and beta-endorphin-immunoreactive neurons in the rat hypothalamic arcuate nucleus,” Acupuncture Research, vol. 12, no. 3, pp. 235–238, 1987. View at: Google Scholar
  59. J. S. Han and C. W. Xie, “Dynorphin: potent analgesic effect in spinal cord of the rat,” Life Sciences, vol. 31, no. 16-17, pp. 1781–1784, 1982. View at: Google Scholar
  60. W. Zhang, J. H. Tian, and J. S. Han, “Analgesic effect of dynorphin A (1~13) and its antagonistic effect on morphine analgesia in rat brain in the cold water tail flick test assay,” Chinese Journal of Neuroscience, vol. 15, no. 2, pp. 120–124, 1999. View at: Google Scholar
  61. J. S. Han, X. H. Chen, S. L. Sun et al., “Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF,” Pain, vol. 47, no. 3, pp. 295–298, 1991. View at: Publisher Site | Google Scholar
  62. G. X. Xie, Z. F. Zhou, and J. S. Han, “Acupuncture analgesic effects of microinjection of enkephalin, β-endorphin and substance P antibodies into the CNS,” Acta Physiologica Sinica, vol. 2, no. 1, pp. 10–11, 1982. View at: Google Scholar
  63. X. H. Chen, S. F. Guo, C. G. Chang, and J. S. Han, “Optimal conditions for eliciting maximal electroacupuncture analgesia with dense-and-disperse mode stimulation,” American Journal of Acupuncture, vol. 22, no. 1, pp. 47–53, 1994. View at: Google Scholar

Copyright © 2012 Li-Li Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views3877
Downloads873
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.